Menu
What we do
Portfolio
News
Who we are
About
Team
Contact
Logins
LP Login
We are investing in the
future of healthcare, see
our most recent news.
9.13.22
Upward Health Announces Growth Equity Financing Led by Heritage Group
9.13.22
Upward Health Announces Growth Equity Financing Led by Heritage Group
Filter by:
Blog
News
Blog
October 4, 2022
The Dye that Binds: Advances in Tumor Visualization Now Help Surgeons See Cancer in Real-Time
October 4, 2022
The Dye that Binds: Advances in Tumor Visualization Now Help Surgeons See Cancer in Real-Time
News
September 12, 2022
Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study
September 12, 2022
Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study
News
August 23, 2022
Upward Health Awarded ACO REACH Model Contract by CMS
August 23, 2022
Upward Health Awarded ACO REACH Model Contract by CMS
News
July 25, 2022
Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey
July 25, 2022
Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey
News
July 18, 2022
Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests
July 18, 2022
Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests
News
June 14, 2022
Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System
June 14, 2022
Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System
News
May 9, 2022
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
May 9, 2022
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
News
May 9, 2022
Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial
May 9, 2022
Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial
News
May 5, 2022
Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…
May 5, 2022
Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…
News
March 29, 2022
Willow® Expands Product Suite and Unveils Willow Go™, Its Fully In-Bra Wearable Breast Pump for Only $329
March 29, 2022
Willow® Expands Product Suite and Unveils Willow Go™, Its Fully In-Bra Wearable Breast Pump for Only $329
News
January 25, 2022
200th Treatment Milestone for AIRFLOW-3 COPD Trial
January 25, 2022
200th Treatment Milestone for AIRFLOW-3 COPD Trial
News
December 23, 2021
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
December 23, 2021
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
News
December 16, 2021
Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry
December 16, 2021
Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry
News
November 4, 2021
Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.
November 4, 2021
Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.
News
October 14, 2021
Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing
October 14, 2021
Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing
News
October 7, 2021
Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer
October 7, 2021
Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer
News
September 22, 2021
Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan
September 22, 2021
Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan
News
September 17, 2021
CVRx Added to Russell 2000® and 3000® Indexes
September 17, 2021
CVRx Added to Russell 2000® and 3000® Indexes
News
August 11, 2021
Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone
August 11, 2021
Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone
News
July 20, 2021
Neuspera Medical Announces Close of a $65M Series C Equity Financing
July 20, 2021
Neuspera Medical Announces Close of a $65M Series C Equity Financing
News
June 29, 2021
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
June 29, 2021
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
News
June 15, 2021
Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System
June 15, 2021
Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System
News
June 10, 2021
Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative
June 10, 2021
Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative
News
April 21, 2021
FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round
April 21, 2021
FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round
News
March 31, 2021
Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test
March 31, 2021
Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test
News
March 16, 2021
ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition
March 16, 2021
ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition
News
March 4, 2021
Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership
March 4, 2021
Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership
News
March 4, 2021
ControlRad® Announces FDA Clearance for ControlRad Select
March 4, 2021
ControlRad® Announces FDA Clearance for ControlRad Select
